Targacept Inc (TRGT.OQ)
TRGT.OQ on NASDAQ Stock Exchange Global Select Market
5.04USD
10:49am EDT
5.04USD
10:49am EDT
Price Change (% chg)
$0.04 (+0.80%)
$0.04 (+0.80%)
Prev Close
$5.00
$5.00
Open
$5.00
$5.00
Day's High
$5.04
$5.04
Day's Low
$4.96
$4.96
Volume
5,306
5,306
Avg. Vol
59,397
59,397
52-wk High
$5.77
$5.77
52-wk Low
$3.86
$3.86
About
Targacept, Inc. is a biopharmaceutical company. The Company is engaged in the design, discovery and development of NNR Therapeutics for the treatment of diseases and disorders of the nervous system. The Company's NNR Therapeutics target neuronal nicotinic receptors (NNRs). As of December 31, 2011, the Company had multiple... (more)
Overall
| Beta: | 3.16 |
| Market Cap (Mil.): | $168.09 |
| Shares Outstanding (Mil.): | 33.62 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| TRGT.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 37.93 | 37.76 |
| EPS (TTM): | -0.52 | -- | -- |
| ROI: | -9.81 | 19.48 | 18.76 |
| ROE: | -9.95 | 20.17 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Eisai Co., Ltd (4523.T) | ¥4,165 | +20.00 |
| Pfizer Inc. (PFE.N) | $29.18 | -0.05 |
| Johnson & Johnson (JNJ.N) | $93.90 | +0.40 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Merck & Co., Inc. (MRK.N) | $48.13 | -0.04 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Abbott Laboratories (ABT.N) | $36.91 | +0.28 |
| Sanofi SA (SASY.PA) | €76.26 | -3.91 |
| AstraZeneca plc (AZN.L) | 3,311.50p | -23.50 |
| GlaxoSmithKline plc (GSK.L) | 1,706.50p | +22.50 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

